文献速递腹部CTMR

主胰管扩张的CT与MR评估:放射科医生鉴别良恶性的指南

CT and MR evaluation of main pancreatic duct dilation: A radiologist's guide to differentiating benign from malignant causes.
PubMed 文献 · Eur J Radiol · 2026-03-15

主胰管扩张涵盖多种良恶性病因,鉴别对患者管理至关重要。薄层双期CT对胰腺导管腺癌、血管侵犯和转移评估有效,MR(尤其MRCP)软组织对比和导管显示更优,利于评估细微狭窄、囊性病变和导管内异常。良性病因常表现为渐进性狭窄、多发狭窄或光滑轮廓不规则,恶性病因常表现为 abrupt 截断、占位效应和上游萎缩。识别「双管征」、强化壁结节或弥散受限可提高诊断信心。

要点

  • 恶性扩张多呈 abrupt 截断伴占位效应和上游萎缩,良性多呈渐进性狭窄或多发狭窄。
  • MRCP对导管形态、细微狭窄和导管内病变显示优于CT,薄层双期CT利于评估血管侵犯和转移。
  • 「双管征」、强化壁结节和弥散受限是提示恶性的重要征象。

关键影像表现/征象

  • 良性病因(慢性胰腺炎伴导管结石、炎症后狭窄、低级别主胰管型IPMN、局灶性自身免疫性胰腺炎)常表现为渐进性导管狭窄、多发狭窄或光滑轮廓不规则,无 abrupt 截断。
  • 恶性病因(PDAC、高级别IPMN、壶腹癌、胰腺神经内分泌癌、转移瘤)典型表现为 abrupt 导管截断、相关占位效应和上游萎缩。
  • 「双管征」、强化壁结节和弥散受限是提高诊断信心的影像模式。

临床应用与阅片要点

  • 阅片时应关注导管狭窄形态:渐进性、多发或光滑轮廓不规则多提示良性,abrupt 截断伴占位效应和上游萎缩提示恶性。
  • MRCP有助于显示细微狭窄、囊性病变和导管内异常,薄层双期CT有助于评估血管侵犯和转移。
  • 需注意技术优化、识别伪影并结合临床资料,避免误判。

局限性

  • 本文为综述,未报告系统检索策略、纳入文献数量及证据分级。
  • 未提供各影像征象的敏感度、特异度或诊断阈值等定量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Main pancreatic duct (MPD) dilation is an imaging finding that encompasses a broad spectrum of benign and malignant etiologies. Differentiating between these conditions is critical for appropriate patient management, and radiologists play a central role in this diagnostic process. CT and MR, particularly with MR cholangiopancreatography (MRCP), are crucial for assessing ductal morphology, parenchymal changes, and associated lesions. Thin-slice dual-phase CT provides excellent spatial resolution and is particularly effective for evaluating pancreatic ductal adenocarcinoma (PDAC), vascular invasion, and metastatic disease. Conversely, MR offers superior soft-tissue contrast and ductal delineation, allowing detailed assessment of subtle strictures, cystic lesions, and intraductal abnormalities. Benign causes of MPD dilation include chronic pancreatitis with ductal calculi, post-inflammatory strictures, low-grade main-duct intraductal papillary mucinous neoplasms (IPMNs), and focal autoimmune pancreatitis. These entities often show gradual ductal narrowing, multiple strictures, or smooth contour irregularities without abrupt cutoff. In contrast, malignant etiologies - such as PDAC, high-grade IPMN, ampullary carcinoma, pancreatic neuroendocrine carcinoma (NET), and metastases - typically present with abrupt ductal truncation, associated mass effect, and upstream atrophy. Recognition of imaging patterns such as the "double duct sign," enhancing mural nodules, or restricted diffusion improves diagnostic confidence. Technical optimization of CT and MR protocols, awareness of artifacts, and correlation with clinical data are essential to avoid misinterpretation. Radiologists must integrate morphological, functional, and clinical information to ensure accurate characterization of MPD dilation and guide optimal management.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Maino C, Castagnoli F, Vernuccio F, et al. CT and MR evaluation of main pancreatic duct dilation: A radiologist's guide to differentiating benign from malignant causes. Eur J Radiol. 2026. PMID: 41932105. doi:10.1016/j.ejrad.2026.112803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。